Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02404402 · ClinicalTrials.gov registry record · NA

LED Treatment to Improve Cognition and Promote Recovery in TBI

A NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT02404402 is a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 8 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02404402, a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).

Interventions

  • OTHER LED
  • OTHER sham LED

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2015-05-01
Est. Completion 2027-10-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02404402

The ClinicalTrials.gov registry entry for NCT02404402 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which LED is the first listed.

NCT02404402 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02404402 about?

NCT02404402 is a clinical study titled "LED Treatment to Improve Cognition and Promote Recovery in TBI". This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).

What is the current status of trial NCT02404402?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2015-05-01. Estimated completion is 2027-10-31.

What conditions does trial NCT02404402 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT02404402?

The interventions under investigation include: LED (OTHER), sham LED (OTHER).

Who is sponsoring clinical trial NCT02404402?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02404402 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.